UPDATE 1-Rare liver disorder drug from Jazz wins U.S. approval
March 30 (Reuters) - The U.S. Food and Drug Administration has cleared Jazz Pharmaceuticals Plc's drug to treat a rare kind of liver disease, making it the first treatment to win U.S. approval for the condition.
No comments:
Post a Comment